TY - JOUR
T1 - Hypertonic Saline Prevents Inflammation, Injury, and Impaired Intestinal Transit after Gut Ischemia/Reperfusion by Inducing Heme Oxygenase 1 Enzyme
AU - Attuwaybi, Bashir
AU - Kozar, Rosemary A.
AU - Gates, Keith S.
AU - Moore-Olufemi, Stacey
AU - Sato, Norio
AU - Weisbrodt, Norman W.
AU - Moore, Frederick A.
AU - Cooney, Robert N.
AU - Ford, Henri
AU - Barquist, Eriq
PY - 2004/4
Y1 - 2004/4
N2 - Background: Hypertonic saline (HTS) has been shown to modulate the inflammatory response after shock. We have previously demonstrated that heme oygenase-1 (HO-1) induction is protective against gut dysfunction in models of shock-induced gut ischemia/reperfusion (I/R). We therefore hypothesized that HTS prevents gut inflammation, injury, and impaired transit by inducing HO-1 in a model of gut I/R. Methods: Rats underwent 60 minutes of superior mesenteric artery occlusion (SMAO) and then were resuscitated with 4 mL/kg of HTS, an equal volume of lactated Ringer's (LR) solution (4 mL/kg, low volume), or equal salt LR solution (32 mL/kg, high volume) and compared with SMAO alone or shams. A separate group was pretreated with the HO-1 blocker Sn protoporphyrin IX (SNP IX) before SMAO plus HTS. At 6 hours of reperfusion, transit was determined and ileum harvested for HO-1 (anti-inflammatory) and inducible nitric oxide synthase (proinflammatory) immunoreactivity, myeloperoxidase (MPO) activity, and histologic injury. Data are expressed as mean ± SEM (analysis of variance). Results: Intestinal transit was severely impaired after SMAO (2.5 ± 0.1), improved with low- and high-volume LR solution (3.2 ± 0.2 and 3.1 ± 0.1, not significant), but returned to sham (4.6 ± 0.2) with HTS (4.8 ± 0.2). Pretreatment with SNP abrogated this protective effect. Myeloperoxidase activity was significantly increased by SMAO (SMAO, 2.3 ± 0.3; sham, 0.4 ± 0.05), lessened by low- and high-volume LR solution (1.5 ± 0.3 and 1.7 ± 0.4), but returned to sham levels with HTS (1.0 ± 0.01). Activity with SNP IX pretreatment was significantly increased (4.04 ± 0.8). Mucosal injury followed a similar pattern. Inducible nitric oxide synthase was increased by SMAO and low- and high-volume LR solution (0.8 ± 0.2, 0.8 ± 0.03, and 0.8 ± 0.02, respectively; sham, 0.5 ± 0.02), but significantly reduced by HTS (0.7 ± 0.02). HO-1 was induced by SMAO and low-and high-volume LR solution (0.33 ± 0.02, 0.32 ± 0.03, and 0.37 ± 0.4, respectively; sham, 0.0 ± 0.0), but was further increased with HTS (0.49 ± 0.04). Conclusion: HTS resuscitation protects against inflammation, injury, and impaired intestinal transit after gut I/R in part by inducing HO-1. This is a novel mechanism of HO-1 protection.
AB - Background: Hypertonic saline (HTS) has been shown to modulate the inflammatory response after shock. We have previously demonstrated that heme oygenase-1 (HO-1) induction is protective against gut dysfunction in models of shock-induced gut ischemia/reperfusion (I/R). We therefore hypothesized that HTS prevents gut inflammation, injury, and impaired transit by inducing HO-1 in a model of gut I/R. Methods: Rats underwent 60 minutes of superior mesenteric artery occlusion (SMAO) and then were resuscitated with 4 mL/kg of HTS, an equal volume of lactated Ringer's (LR) solution (4 mL/kg, low volume), or equal salt LR solution (32 mL/kg, high volume) and compared with SMAO alone or shams. A separate group was pretreated with the HO-1 blocker Sn protoporphyrin IX (SNP IX) before SMAO plus HTS. At 6 hours of reperfusion, transit was determined and ileum harvested for HO-1 (anti-inflammatory) and inducible nitric oxide synthase (proinflammatory) immunoreactivity, myeloperoxidase (MPO) activity, and histologic injury. Data are expressed as mean ± SEM (analysis of variance). Results: Intestinal transit was severely impaired after SMAO (2.5 ± 0.1), improved with low- and high-volume LR solution (3.2 ± 0.2 and 3.1 ± 0.1, not significant), but returned to sham (4.6 ± 0.2) with HTS (4.8 ± 0.2). Pretreatment with SNP abrogated this protective effect. Myeloperoxidase activity was significantly increased by SMAO (SMAO, 2.3 ± 0.3; sham, 0.4 ± 0.05), lessened by low- and high-volume LR solution (1.5 ± 0.3 and 1.7 ± 0.4), but returned to sham levels with HTS (1.0 ± 0.01). Activity with SNP IX pretreatment was significantly increased (4.04 ± 0.8). Mucosal injury followed a similar pattern. Inducible nitric oxide synthase was increased by SMAO and low- and high-volume LR solution (0.8 ± 0.2, 0.8 ± 0.03, and 0.8 ± 0.02, respectively; sham, 0.5 ± 0.02), but significantly reduced by HTS (0.7 ± 0.02). HO-1 was induced by SMAO and low-and high-volume LR solution (0.33 ± 0.02, 0.32 ± 0.03, and 0.37 ± 0.4, respectively; sham, 0.0 ± 0.0), but was further increased with HTS (0.49 ± 0.04). Conclusion: HTS resuscitation protects against inflammation, injury, and impaired intestinal transit after gut I/R in part by inducing HO-1. This is a novel mechanism of HO-1 protection.
KW - Heme oxygenase-1
KW - Hypertonic saline
KW - Inducible nitric oxide synthase (iNOS)
KW - Intestinal transit
KW - Ischemia/reperfusion
UR - http://www.scopus.com/inward/record.url?scp=11144354381&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=11144354381&partnerID=8YFLogxK
U2 - 10.1097/01.TA.0000119686.33487.65
DO - 10.1097/01.TA.0000119686.33487.65
M3 - Article
C2 - 15187737
AN - SCOPUS:11144354381
VL - 56
SP - 749
EP - 759
JO - Journal of Trauma and Acute Care Surgery
JF - Journal of Trauma and Acute Care Surgery
SN - 2163-0755
IS - 4
ER -